β-Amyloid Peptide Activates Non-α7 Nicotinic Acetylcholine Receptors in Rat Basal Forebrain Neurons

Journal of Neurophysiology

Volumn 90, Issue 5, 2003, Pages 3130-3136

  Fu, Wen ^a   Jhamandas, Jack H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AR R17779; BUNGAROTOXIN RECEPTOR; CYTISINE; EPIBATIDINE; MECAMYLAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; UB 165; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CHOLINERGIC NERVE CELL; COGNITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FOREBRAIN; MEMORY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SENILE PLAQUE;

AMYLOID BETA-PROTEIN; ANIMALS; MALE; MEMBRANE POTENTIALS; NEURONS; PEPTIDE FRAGMENTS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 0242593724     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00616.2003     Document Type: Article

References (43)

1. Alkondon M and Albuquerque EX. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther 265: 1455-1473, 1993.
2. Auld DS, Kornecook TJ, Bastianetto S, and Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68: 209-245, 2002.
3. Bowen DM, Smith CB, White P, and Davison AN. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459-496, 1976.
4. Boyd RT. The molecular biology of neuronal nicotinic acetylcholine receptors. Crit Rev Toxicol 27: 299-318, 1997.
5. Cummings JL and Cole G. Alzheimer disease. J Am Med Assoc 287: 2335-2338, 2002.
6. Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, and LaDu MJ. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277: 32046-32053, 2002.
7. Davies P and Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403, 1976.
8. Dineley KT, Bell KA, Bui D, and Sweatt JD. β-amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Biol Chem 277: 25056-25061, 2002.
9. Easaw JC, Petrov T, and Jhamandas JH. An electrophysiological study of neurons in the horizontal limb of the diagonal band of Broca. Am J Physiol 272: C163-C172, 1997.
10. Fraser SP, Suh YH, and Djamgoz MB. Ionic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments. Trends Neurosci 20: 67-72, 1997.
11. Grassi F, Palma E, Tonini R, Amici M, Ballivet M, and Eusebi F. Amyloid beta (1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors. J Physiol 547: 147-157, 2003.
12. Griffith WH, Taylor L, and Davis MJ. Whole-cell and single-channel calcium currents in guinea pig basal forebrain neurons. J Neurophysiol 71: 2359-2376, 1994.
13. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20: 154-159, 1997.
14. Harvey SC, Maddox FN, and Luetje CW. Multiple determinants of dihydro-β-erythroidine sensitivity on rat neuronal nicotinic receptor α subunits. J Neurochem 67: 1953-1959, 1996.
15. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, and Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci USA 96: 3228-3233, 1999.
16. Jassar BS, Harris KH, Ostashewski PM, and Jhamandas JH. Ionic mechanisms of action of neurotensin in acutely dissociated neurons from the diagonal band of Broca of the rat. J Neurophysiol 81: 234-246, 1999.
17. Jhamandas JH, Cho C, Jassar B, Harris K, MacTavish D, and Easaw J. Cellular mechanisms for amyloid β-protein activation of rat cholinergic basal forebrain neurons. J Neurophysiol 86: 1312-1320, 2001.
18. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T, and Akaike A. Nicotinic receptor stimulation protects neurons against β-amyloid toxicity. Ann Neurol 42: 159-163, 1997.
19. Kihara T, Shimohama S, Urushitani M, Sawada H, Kimura J, Kume T, Maeda T, and Akaike A. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res 792: 331-334, 1998.
20. Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, Ball MJ, and Roher AE. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer's disease brains. J Biol Chem 271: 4077-4081, 1996.
21. Liu Q, Kawai H, and Berg DK. β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci USA 98: 4734-4739, 2001.
22. Marchi M, Risso F, Viola C, Cavazzani P, and Raiteri M. Direct evidence that release-stimulating α7 nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J Neurochem 80: 1071-1078, 2002.
23. Martin-Ruiz CM, Court JA, Molnar E, Lee M, Gotti C, Mamalaki A, Tsouloufis T, Tzartos S, Ballard C, Perry RH, and Perry EK. α4 but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J Neurochem 73: 1635-1640, 1999.
24. 1-42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110: 199-211, 2002.
25. Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greenguard P, and Buxbaum JD. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. J Am Med Assoc 283: 1571-1577, 2000.
26. Paterson D and Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61: 75-111, 2000.
27. Perry DC, Xiao Y, Nguyen HN, Musachio JL, Davila-Garcia MI, and Kellar KJ. Measuring nicotinic receptors with characteristics of α4β2, α3β2, and α3β4 subtypes in rat tissues by autoradiography. J Neurochem 82: 468-481, 2002.
28. Perry EK, Gibson PH, Blessed G, Perry RH, and Tomlinson BE. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci 34: 247-265, 1977.
29. 1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci 21: RC120, 2001.
30. Plant LD, Boyle JP, Smith IF, Peers C, and Pearson HA. The production of amyloid β peptide is a critical requirement for the viability of central neurons. J Neurosci 23: 5531-5535, 2003.
31. Price DL. New perspectives on Alzheimer's disease. Annu Rev Neurosci 9: 489-512, 1986.
32. Rogers SW, Gahring LC, Collins AC, and Marks M. Age-related changes in neuronal nicotinic acetylcholine receptor subunit α4 expression are modified by long-term nicotine administration. J Neurosci 18: 4825-4832, 1998.
33. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399: A23-A31, 1999.
34. Selkoe DJ. Alzheimer's disease: gene, proteins, and therapy. Physiol Rev 81: 741-766, 2001.
35. Shao Z and Yakel JL. Single channel properties of neuronal nicotinic ACh receptors in stratum radiatum interneurons of rat hippocampal slices. J Physiol 527: 507-513, 2000.
36. Sharples CG, Kraiser S, Soliakov L, Marks MJ, Collins AC, Washburn M, Wright E, Spencer JA, Gallagher T, Whiteaker P, and Wonnacott S. UB-165: a novel nicotinic agonist with subtype selectivity implicates the α4β2 subtype in the modulation of dopamine release from rat striatal synaptosomes. J Neurosci 20: 2783-2791, 2000.
37. Tozaki H, Matsumoto A, Kanno T, Nagai K, Nagata T, Yamamoto S, and Nishizaki T. The inhibitory and facilitatory actions of amyloid-beta peptides on nicotinic ACh receptors and AMPA receptors. Biochem Biophys Res Commun 294: 42-45, 2002.
38. 1-42 binds to α7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 275: 5626-5632, 2000a.
39. 1-42 binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors. J Neurochem 75: 1155-1161, 2000b.
40. Warpman U and Nordberg A. Epibatidine and ABT 418 reveal selective losses of alpha4 beta2 nicotinic receptors in Alzheimer brains. Neuroreport 6: 2419-2423, 1995.
41. Wevers A, Witter B, Moser N, Burghaus L, Banerjee C, Steinlein OK, Schutz U, de Vos RA, Steur EN, Lindstrom J, and Schroder H. Classical Alzheimer features and cholinergic dysfunction: towards a unifying hypothesis? Acta Neurol Scand Suppl 176: 42-48, 2000.
42. Whiteaker P, Sharples CG, and Wonnacott S. Agonist-induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol Pharmacol 53: 950-962, 1998.
43. Yankner BA. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16: 921-932, 1996.